- $49.49bn
- $51.68bn
- $6.95bn
Agilent Technologies Inc reports results for the quarter ended October 31 - Earnings Summary
Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat
Brief: Agilent Q4 Revenue USD 1,701 Million Vs. IBES Estimate USD 1,672 Million
Brief: Agilent Technologies - Announces New Organizational Structure
Morning Bid Americas: Treasuries rally on Bessent pick, dollar retreats
What to Watch in the Week Ahead and on Monday, November 25
Brief: Agilent Increases Cash Dividend To 24.8 Cents Per Share
Bernstein expects a 'not so scary' Q3 for US life sciences firms
Brief: Agilent Technologies Inc Files For Two-Part Senior Notes Offering Size Not Disclosed - SEC Filing
U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley
U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera
Agilent Technologies rises on Q3 results beat
U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon
Agilent Technologies Inc reports results for the quarter ended in July - Earnings Summary
Agilent beats quarterly results on strong demand from biotech clients
Brief: Agilent Q3 Revenue USD 1,578 Million Vs. IBES Estimate USD 1,558 Million
Agilent Technologies Inc expected to post earnings of $1.26 a share - Earnings Preview
Deals of the day-Mergers and acquisitions
Brief: Agilent Technologies To Acquire BIOVECTRA for $925 Million